UPDATE: Jefferies Assumes Neurocrine Bio. (NBIX) at Buy
Tweet Send to a Friend
(Updated - June 6, 2022 8:08 AM EDT)
Jefferies analyst Akash Tewari assumes coverage on Neurocrine Bio. (NASDAQ: NBIX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Akash Tewari assumes coverage on Neurocrine Bio. (NASDAQ: NBIX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
